Crossmark

Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945

Crossref DOI link: https://doi.org/10.1186/s40478-018-0510-8

Published Online: 2018-02-15

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Beckmann, Nicolau

Giorgetti, Elisa

Neuhaus, Anna

Zurbruegg, Stefan

Accart, Nathalie

Smith, Paul

Perdoux, Julien

Perrot, Ludovic

Nash, Mark

Desrayaud, Sandrine

Wipfli, Peter

Frieauff, Wilfried

Shimshek, Derya R.
More Information

Article History

Received: 26 January 2018

Accepted: 26 January 2018

First Online: 15 February 2018

Competing interests

: All authors are, or have been, employees and shareholders of Novartis Pharma AG, Basel Switzerland.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.